£179.10

Springer Varicella-zoster Virus: 342 (Current Topics in Microbiology and Immunology, 342)

Price data last checked 136 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£179 today · previous high £179 · all-time low £160

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 595 days • 595 data points (No recent data available)

Historical
Generating forecast...
£179.10 £157.87 £162.50 £167.13 £171.77 £176.40 £181.03 09 June 2024 04 November 2024 02 April 2025 28 August 2025 24 January 2026

Price Distribution

Price distribution over 595 days • 6 price levels

Days at Price
Current Price
54 days 143 days 43 days 139 days 19 days 197 days · current 0 49 99 148 197 £160 £168 £172 £173 £176 £179 Days at Price

Price Analysis

Most common price: £179 (197 days, 33.1%)

Price range: £160 - £179

Price levels: 6 different prices over 595 days

Description

Varicella-zostervirus(VZV)isamedicallyimportanthumanherpesvirus,belo- ingtothesubfamilyAlphaherpesviridae. Thecapacitytopersistinsensoryneurons isade?ningcharacteristicoftheAlphaherpesviridaesubgroupwhichalsoincludes herpessimplexvirus1and2;likeVZV,simianvaricellavirus(SVV),pseudorabies virus-1(PRV-1),andequineherpesvirus-1(EHV-1)belongtotheVaricellovirus genus. ThebasicelementsoftheinfectiouscycleofVZVinthehumanhostarethat infectionofthena?vehostresultsinvaricella,commonlyknownaschickenpox, latencyisestablishedinsensoryganglia,andreactivationcauseszosteror"sh- gles. "Therelationshipbetweenthecausative agentofvaricellaandzoster was demonstratedmorethan100yearsagowhenchildreninoculatedwithmaterialfrom zosterlesionswereshowntodevelopvaricella. Thelocalizeddistributionofthe zosterrashwasalsorecognizedasdemarcatingthedematomeinnervatedbyaxons fromneuronsineachofthesensoryganglia. Earlyelectronmicroscopystudies showedthatvirusparticleswerepresentinhighconcentrationsinthevesicular ?uidfrombothvaricellaandzosterlesions,andVZVwasamongthe?rstviruses propagatedinvitrobyJohnEndersandThomasWeller. Theintroductionofim- nosuppressivetherapiesformalignancyledtoobservationssuggestingtheneed forcell-mediatedimmunityinthehostresponsetovaricellaanditsroleinma- tainingVZVlatency. Fortunately,earlystudiesofthemolecularvirologyofVZV revealedthatitwasinhibitedbyinterferencewiththethymidinekinasegene,and thelife-threateningandoftenfatalVZVinfectionsexperiencedbythesepatients becametreatablewithantiviraldrugs. Subsequently,thecapacitytogrowVZVin tissueculturewasexploitedtocreatealiveattenuatedVZVvaccinebyMichiaki Tashihaki. Whilenowtakenforgranted,theseearlyinsightsaboutVZVandits characteristicsasahumanpathogenaswellasthedevelopmentofeffectivean- viral drugs and vaccines occurred over many decades. Importantly, these early observationssetthestagefortheremarkableprogressthathasbeenmadeinour understandingofthemolecularbiologyofVZV,thesubtletiesofitstropismfor differentiatedhumancells,includinglymphocytesaswellasskinandneurons,and themechanismsbywhichthevirusachievesanequilibriumwiththehostsothatit persistsnotjustintheindividualbutinthehumanpopulation. v vi Preface Thepurposeofthisvolumeistoreviewkeyareasofprogressinthe?eldofVZV research,aswellasworkontherelatedSVV,writtenbythosewhohavecontributed manyofthenew? ndingsthathaveenrichedourknowledgeoftheuniquech- acteristicsofthisubiquitoushumanpathogen. AlthoughtheVZVgenomeisthe smallestamongthehumanherpesviruses,therapidlyacceleratingpaceofdiscovery about VZV and VZV-host interactions re?ected in these reviews promises to continueasnewtoolsareavailableandnewhypothesesaregeneratedtoexplain howVZVhascreatedandmaintaineditsnicheinthehuman"virome"Therelationshipbetweenthecausative agentofvaricellaandzoster was demonstratedmorethan100yearsagowhenchildreninoculatedwithmaterialfrom zosterlesionswereshowntodevelopvaricella. Thelocalizeddistributionofthe zosterrashwasalsorecognizedasdemarcatingthedematomeinnervatedbyaxons fromneuronsineachofthesensoryganglia. Earlyelectronmicroscopystudies showedthatvirusparticleswerepresentinhighconcentrationsinthevesicular ?uidfrombothvaricellaandzosterlesions,andVZVwasamongthe?rstviruses propagatedinvitrobyJohnEndersandThomasWeller. Theintroductionofim- nosuppressivetherapiesformalignancyledtoobservationssuggestingtheneed forcell-mediatedimmunityinthehostresponsetovaricellaanditsroleinma- tainingVZVlatency. Fortunately,earlystudiesofthemolecularvirologyofVZV revealedthatitwasinhibitedbyinterferencewiththethymidinekinasegene,and thelife-threateningandoftenfatalVZVinfectionsexperiencedbythesepatients becametreatablewithantiviraldrugs. Subsequently,thecapacitytogrowVZVin tissueculturewasexploitedtocreatealiveattenuatedVZVvaccinebyMichiaki Tashihaki. Whilenowtakenforgranted,theseearlyinsightsaboutVZVandits characteristicsasahumanpathogenaswellasthedevelopmentofeffectivean- viral drugs and vaccines occurred over many decades. Importantly, these early observationssetthestagefortheremarkableprogressthathasbeenmadeinour understandingofthemolecularbiologyofVZV,thesubtletiesofitstropismfor differentiatedhumancells,includinglymphocytesaswellasskinandneurons,and themechanismsbywhichthevirusachievesanequilibriumwiththehostsothatit persistsnotjustintheindividualbutinthehumanpopulation. v vi Preface Thepurposeofthisvolumeistoreviewkeyareasofprogressinthe?eldofVZV research,aswellasworkontherelatedSVV,writtenbythosewhohavecontributed manyofthenew?ndingsthathaveenrichedourknowledgeoftheuniquech- acteristicsofthisubiquitoushumanpathogen. AlthoughtheVZVgenomeisthe smallestamongthehumanherpesviruses,therapidlyacceleratingpaceofdiscovery about VZV and VZV-host interactions re?ected in these reviews promises to continueasnewtoolsareavailableandnewhypothesesaregeneratedtoexplain howVZVhascreatedandmaintaineditsnicheinthehuman"virome"sos- cessfully. Further improvements in the clinical management of VZV infection shouldemergeinparallelwithbetterinsightsintoVZVmolecularvirologyand pat

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Varicella-zoster Virus: 342 (Current Topics in Microbiology and Immunology, 342)
98% match

Varicella-zoster Virus: 342 (Current Topics in Microbiology and Immunology, 342)

Springer

£177.97 11 Jan 2026
Herpes Zoster: Postherpetic Neuralgia and Other Complications: Focus on Treatment and Prevention
96% match

Herpes Zoster: Postherpetic Neuralgia and Other Complications: Focus on Treatment and Prevention

Adis

£81.44 11 Mar 2026
Herpes Zoster: Postherpetic Neuralgia and Other Complications: Focus on Treatment and Prevention
95% match

Herpes Zoster: Postherpetic Neuralgia and Other Complications: Focus on Treatment and Prevention

Adis

£73.75 24 Jan 2026
Human Herpesviruses HHV-6A, HHV-6B & HHV-7: Diagnosis and Clinical Management: Volume 12 (Perspectives in Medical Virology, Volume 12)
95% match

Human Herpesviruses HHV-6A, HHV-6B & HHV-7: Diagnosis and Clinical Management: Volume 12 (Perspectives in Medical Virology, Volume 12)

Elsevier

£78.74 14 Feb 2026
Herpesviridae: Viral Structure, Life Cycle and Infections: Viral Structure, Life Cycle & Infections
95% match

Herpesviridae: Viral Structure, Life Cycle and Infections: Viral Structure, Life Cycle & Infections

£94.84 08 Mar 2026
Vaccinia Virus: Methods and Protocols: 2023 (Methods in Molecular Biology, 2023)
95% match

Vaccinia Virus: Methods and Protocols: 2023 (Methods in Molecular Biology, 2023)

Humana

£133.80 03 Apr 2026
Humana Vaccinia Virus and Poxvirology Methods and Protocols 890
94% match

Humana Vaccinia Virus and Poxvirology Methods and Protocols 890

Humana

£127.50 18 Apr 2026
Immunobiology and Prophylaxis of Human Herpesvirus Infections: 278 (Advances in Experimental Medicine and Biology, 278)
94% match

Immunobiology and Prophylaxis of Human Herpesvirus Infections: 278 (Advances in Experimental Medicine and Biology, 278)

Springer

£77.71 13 Mar 2026
Natural History of Varicella-Zoster Virus
94% match

Natural History of Varicella-Zoster Virus

CRC Press

£185.00 02 Feb 2026
Human Herpesvirus-6: General Virology, Epidemiology, and Clinical Pathology (Volume 12) (Perspectives in Medical Virology, Volume 12)
94% match

Human Herpesvirus-6: General Virology, Epidemiology, and Clinical Pathology (Volume 12) (Perspectives in Medical Virology, Volume 12)

Elsevier

£39.81 18 Feb 2026
Human Herpesviruses: 1045 (Advances in Experimental Medicine and Biology, 1045)
94% match

Human Herpesviruses: 1045 (Advances in Experimental Medicine and Biology, 1045)

Springer

£147.72 24 Jan 2026
Poxviruses (Birkhäuser Advances in Infectious Diseases)
94% match

Poxviruses (Birkhäuser Advances in Infectious Diseases)

Birkhauser

£102.30 24 Jan 2026
Herpes Simplex Virus: Methods and Protocols: 1144 (Methods in Molecular Biology, 1144)
94% match

Herpes Simplex Virus: Methods and Protocols: 1144 (Methods in Molecular Biology, 1144)

Humana

£84.08 07 Feb 2026
Mucocutaneous Manifestations of Viral Diseases: An Illustrated Guide to Diagnosis and Management
94% match

Mucocutaneous Manifestations of Viral Diseases: An Illustrated Guide to Diagnosis and Management

CRC Press

£193.72 14 Jan 2026
Molluscum Contagiosum: Epidemiology, Pathogenesis, Clinical Manifestations, Dermoscopy, Ultrastructure and Evidence Based Treatment
94% match

Molluscum Contagiosum: Epidemiology, Pathogenesis, Clinical Manifestations, Dermoscopy, Ultrastructure and Evidence Based Treatment

£5.29 05 Mar 2026
Alphaherpesviruses: Molecular Biology, Host Interactions and Control
94% match

Alphaherpesviruses: Molecular Biology, Host Interactions and Control

Caister Academic Press Limited

£199.00 25 Jan 2026
Biopharmaceutics and Drug Hypersensitivity (Pharmacology - Research, Safety Testing and Regulation)
94% match

Biopharmaceutics and Drug Hypersensitivity (Pharmacology - Research, Safety Testing and Regulation)

£142.83 11 Mar 2026
Vaccinia Virus and Poxvirology: Methods and Protocols: 269 (Methods in Molecular Biology, 269)
93% match

Vaccinia Virus and Poxvirology: Methods and Protocols: 269 (Methods in Molecular Biology, 269)

Humana

£75.84 19 Apr 2026
Recombinant Poxviruses
93% match

Recombinant Poxviruses

CRC Press

£470.00 26 Jan 2026
Color Atlas of Herpetic Eye Disease: A Practical Guide to Clinical Management
93% match

Color Atlas of Herpetic Eye Disease: A Practical Guide to Clinical Management

Springer

£124.98 29 Jan 2026
Herpes Cure: A Research-Backed Guide to Healing Through Herbal Medicine - 2nd Edition (Vol-1) (Herpes Cure with Ayurvedic Protocol)
93% match

Herpes Cure: A Research-Backed Guide to Healing Through Herbal Medicine - 2nd Edition (Vol-1) (Herpes Cure with Ayurvedic Protocol)

£74.99 07 Jan 2026
Cell Biology of Herpes Viruses: 223 (Advances in Anatomy, Embryology and Cell Biology, 223)
93% match

Cell Biology of Herpes Viruses: 223 (Advances in Anatomy, Embryology and Cell Biology, 223)

Springer

£107.22 23 Jan 2026
The 2025-2030 World Outlook for Genital Herpes Treatments
93% match

The 2025-2030 World Outlook for Genital Herpes Treatments

Out of Stock 06 Feb 2026
Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: 394 (Advances in Experimental Medicine and Biology, 394)
93% match

Antiviral Chemotherapy 4: New Directions for Clinical Application and Research: 394 (Advances in Experimental Medicine and Biology, 394)

Springer

£145.29 27 Jan 2026